Plandai Biotechnology's Technology Could Prove Potent in Battling Alzheimers Disease
October 21, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - October 21, 2014) - In the recently released preliminary results from Plandaí Biotechnology's (OTCQB: PLPL) human clinical trial that compared its green tea extract to a...
Plandai Biotechnology Marketing of First Product to Customers Should Be a Cinch With Proven Higher Bioavailability
October 17, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - October 17, 2014) - Plandaí Biotechnology (OTCQB: PLPL) began to lay out its initial plan this week explaining just how the company will get its first product, a green tea...
Plandai Biotechnology, Inc. Announces Update on Factory and Expected Plan to Market First Phytofare(TM) Product
October 15, 2014 09:27 ET
|
Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - October 15, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"), a developer of highly bioavailable plant extracts for industries including...
Plandai Biotechnology's Green Tea Extract Delivers Favorable Preliminary Results in Human Clinical Trial Conducted in South Africa
September 10, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Sep 10, 2014) - Plandaí Biotechnology (OTCQB: PLPL) recently released the preliminary results from its human clinical trial where the company's green tea...
Plandai Biotechnology up for $2.5 Million Grant in Continued Support From South African Government
May 02, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 2, 2014) - Plandaí Biotechnology (OTCQB: PLPL) could soon receive another injection of money from the South African government, and this time it's in the form...
Plandai Biotechnology Recruiting Now for Human Clinical Trials to Begin in May
April 30, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Apr 30, 2014) - Plandaí Biotechnology (OTCQB: PLPL) has been given the go-ahead to conduct human clinical trials in a 3-month study that will compare the oral...
Plandai Biotechnology Closer to Unzipping the Magic of Phytofare in New Facility
April 04, 2014 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Apr 4, 2014) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) welcomes the month of April with a brand new state of the art production facility that is due to be fully...
Plandai Biotechnology's Human Clinical Trials Offer Significant Proof of Concept
March 26, 2014 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Mar 26, 2014) - What may have been lost in Plandaí Biotechnology's (OTCQB: PLPL) recently reported results from its human clinical trial to test the anti-aging...
Plandai's Medical Marijuana Research Could Benefit From FDA Approval of Clinical Trials
November 26, 2013 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Nov 26, 2013) - Plandaí Biotechnology (OTCQB: PLPL) timed its move into medical marijuana research perfectly. This month the U.S. Food and Drug Administration...
New Report Shows Plandai Biotechnology's Diabetes Research More Important Than Ever
November 19, 2013 08:30 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Nov 19, 2013) - Late last week the International Diabetes Federation (IDF) released a report filled with some staggering statistics in the fight against diabetes....